March 15, 2016

Stocks In News - USFDA

USFDA
  1. Glenmark Pharmaceuticals Inc, USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Frovatriptan Succinate tablets, 2.5 mg.
  2. Frovatriptan Succinate is therapeutic equivalent to listed drug product, Frova tablets of Endo Pharmaceuticals Inc.

No comments:

Post a Comment